Lazard Asset Management
SAGE

Lazard Asset Management’s Sage Therapeutics SAGE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$120K Buy
+13,232
New +$120K ﹤0.01% 1826
2025
Q1
Sell
-222,726
Closed -$1.21M 2550
2024
Q4
$1.21M Buy
+222,726
New +$1.21M ﹤0.01% 1075
2024
Q3
Sell
-8,589
Closed -$93K 2435
2024
Q2
$93K Buy
8,589
+1,764
+26% +$19.1K ﹤0.01% 1772
2024
Q1
$127K Buy
+6,825
New +$127K ﹤0.01% 1458
2021
Q4
Sell
-27,292
Closed -$1.21M 2434
2021
Q3
$1.21M Buy
+27,292
New +$1.21M ﹤0.01% 1033
2021
Q2
Sell
-871
Closed -$65K 2057
2021
Q1
$65K Buy
+871
New +$65K ﹤0.01% 1334
2020
Q4
Sell
-1,658
Closed -$101K 1963
2020
Q3
$101K Sell
1,658
-6,493
-80% -$396K ﹤0.01% 1027
2020
Q2
$338K Buy
8,151
+6,701
+462% +$278K ﹤0.01% 861
2020
Q1
$41K Buy
+1,450
New +$41K ﹤0.01% 1260
2019
Q3
Sell
-5,400
Closed -$988K 1556
2019
Q2
$988K Hold
5,400
﹤0.01% 857
2019
Q1
$858K Hold
5,400
﹤0.01% 865
2018
Q4
$517K Hold
5,400
﹤0.01% 791
2018
Q3
$762K Sell
5,400
-6,629
-55% -$935K ﹤0.01% 781
2018
Q2
$1.88M Buy
12,029
+6,629
+123% +$1.04M ﹤0.01% 666
2018
Q1
$869K Sell
5,400
-3,645
-40% -$587K ﹤0.01% 726
2017
Q4
$1.49M Sell
9,045
-6,855
-43% -$1.13M ﹤0.01% 659
2017
Q3
$990K Sell
15,900
-9,600
-38% -$598K ﹤0.01% 677
2017
Q2
$2.03M Sell
25,500
-900
-3% -$71.6K ﹤0.01% 616
2017
Q1
$1.88M Sell
26,400
-30,900
-54% -$2.2M ﹤0.01% 660
2016
Q4
$2.93M Sell
57,300
-24,300
-30% -$1.24M 0.01% 589
2016
Q3
$3.76M Buy
81,600
+24,300
+42% +$1.12M 0.01% 558
2016
Q2
$1.73M Hold
57,300
﹤0.01% 636
2016
Q1
$1.84M Hold
57,300
﹤0.01% 614
2015
Q4
$3.34M Sell
57,300
-5,125
-8% -$299K 0.01% 583
2015
Q3
$2.64M Sell
62,425
-1,275
-2% -$53.9K 0.01% 570
2015
Q2
$4.65M Buy
+63,700
New +$4.65M 0.01% 528